Hazim Sameer Mohammad Ababneh, M.B.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lymphoma, Large B-Cell, Diffuse | 4 | 2024 | 1405 | 1.740 |
Why?
|
Immunotherapy, Adoptive | 8 | 2024 | 1467 | 1.220 |
Why?
|
Lymphoma, Mantle-Cell | 1 | 2023 | 237 | 0.720 |
Why?
|
Multiple Myeloma | 2 | 2023 | 5146 | 0.490 |
Why?
|
Lymphoma | 1 | 2023 | 1899 | 0.470 |
Why?
|
Soft Tissue Neoplasms | 1 | 2022 | 1158 | 0.450 |
Why?
|
Sarcoma | 1 | 2022 | 1800 | 0.380 |
Why?
|
Antigens, CD19 | 2 | 2023 | 424 | 0.360 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2022 | 5672 | 0.230 |
Why?
|
B-Cell Maturation Antigen | 1 | 2023 | 149 | 0.200 |
Why?
|
Brain Neoplasms | 1 | 2022 | 9026 | 0.190 |
Why?
|
Transplantation, Autologous | 1 | 2022 | 2112 | 0.140 |
Why?
|
Central Nervous System | 1 | 2023 | 1333 | 0.130 |
Why?
|
Lymphedema | 1 | 2023 | 523 | 0.130 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2023 | 2008 | 0.120 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2023 | 2546 | 0.120 |
Why?
|
Radiopharmaceuticals | 1 | 2023 | 2650 | 0.110 |
Why?
|
Prognosis | 2 | 2023 | 29600 | 0.100 |
Why?
|
Humans | 12 | 2024 | 760617 | 0.100 |
Why?
|
Retrospective Studies | 4 | 2023 | 80566 | 0.090 |
Why?
|
Survival Analysis | 1 | 2023 | 10073 | 0.090 |
Why?
|
Lymph Node Excision | 2 | 2023 | 1269 | 0.070 |
Why?
|
Breast Neoplasms | 2 | 2023 | 20988 | 0.060 |
Why?
|
Adult | 3 | 2024 | 220969 | 0.060 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2022 | 9277 | 0.060 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2022 | 5319 | 0.050 |
Why?
|
Axilla | 1 | 2023 | 624 | 0.050 |
Why?
|
Sentinel Lymph Node Biopsy | 1 | 2023 | 732 | 0.040 |
Why?
|
Thoracic Surgery, Video-Assisted | 1 | 2022 | 285 | 0.040 |
Why?
|
Prospective Studies | 1 | 2022 | 54360 | 0.040 |
Why?
|
Female | 4 | 2024 | 392148 | 0.040 |
Why?
|
Lung Neoplasms | 1 | 2022 | 13382 | 0.040 |
Why?
|
Lymphatic Metastasis | 1 | 2023 | 2913 | 0.030 |
Why?
|
Male | 2 | 2024 | 360358 | 0.030 |
Why?
|
Pneumonectomy | 1 | 2022 | 1119 | 0.030 |
Why?
|
Aged | 1 | 2024 | 169042 | 0.020 |
Why?
|
Vaccination | 1 | 2023 | 3370 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2023 | 3868 | 0.020 |
Why?
|
Middle Aged | 1 | 2024 | 220584 | 0.020 |
Why?
|
Lung | 1 | 2022 | 9998 | 0.010 |
Why?
|